Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
oral formulation
Biotech
Pfizer drops oral obesity drug after seeing liver safety concern
Pfizer's near-term weight loss prospects rest on a candidate that is given twice as often as rival medicines in development at Lilly and Novo.
Nick Paul Taylor
Jun 26, 2023 9:11am
Lilly links oral drug to 15% weight loss, setting bar for Pfizer
Jun 26, 2023 8:35am
Merck's chronic cough med gets a nay from FDA
Jan 24, 2022 10:50am
Sensorion sinks as lead hearing loss med fails phase 2
Jan 19, 2022 10:03am
K36 begins with $30M to test multiple myeloma drug from Novartis
Dec 9, 2021 9:15am
Blueprint drops $250M on Lengo for preclinical lung cancer med
Nov 29, 2021 10:20am